跳至主要内容
临床试验/EUCTR2004-003816-47-DE
EUCTR2004-003816-47-DE进行中(未招募)1 期

Clinical pilot study on the effect of Metformin in adipose children and adolescents with insulin-resistanceKlinische Pilotstudie zur Untersuchung der Wirkung von Metformin bei adipösen Kindern und Jugendlichen mit Insulin-Resistenz (IR) - not available

Pädiatrische Endokrinologie, Universitätsmedizin Berlin, Charité0 个研究点开始时间: 2005年10月19日最近更新:
适应症

试验速览

阶段
1 期
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Age from 10 to 17 years
  • BMI > 95. percentile (based on reference percentile according to AGA)
  • Ineffective multidisciplinary treatment of adiposity for at least 6 months
  • In females: highly effective method of birth control used consistently and correctly (e.g. oral contraceptives, see protocol)
  • Are the trial subjects under 18? yes
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) no
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • Diabetes mellitus (according to criteria of the WHO)
  • Decrease in BMI > -2 within 6 months
  • Elevation of GOT and GPT Serum levels (> 150% of the upper referential value)
  • Elevation of Creatinine Serum levels
  • Decrease of Creatinine-clearance
  • All contraindications to Metformin hydrochloride (see protocol)
  • In females: sexual activity and contraindication for oral contraceptives

研究者

发起方
Pädiatrische Endokrinologie, Universitätsmedizin Berlin, Charité

相似试验

进行中(未招募)
不适用
A Prospective Randomised Pilot Study of Metformin and Lifestyle Intervention in the Prevention of Metabolic Syndrome due to Androgen Deprivation Therapy in Prostate Cancer - Metformin use in patients on ADT to prevent Metabolic SyndromePatients with prostate cancer on androgen deprivation therapy (ADT). Randomisation between standard treatment with ADT only, and the additional use of metformin with dietary and exercise advice.Aim is to reduce the prevalence of metabolic syndrome in the intervention arm - this is a condition linked to ADT in prostate cancer patientsMedDRA version: 9.1Level: LLTClassification code 10001186Term: Adenocarcinoma of prostateMedDRA version: 9.1Level: LLTClassification code 10052066Term: Metabolic syndrome
EUCTR2007-002815-20-GBRoyal Surrey County Hospital
尚未招募
2 期
Metformin in Pemphigus VulgarisCondition 1: Pemphigus Vulgaris. Condition 2: Pemphigus foliaceus.Diseases of the skin and subcutaneous tissue
IRCT20170822035834N2Sari University of Medical Sciences40
进行中(未招募)
1 期
Study to evaluate the effect of metformin in the prevention of hyperglycemiain HR[+]/HER2[–] PIK3CA-mutated advanced breast cancer patients treatedwith alpelisib plus endocrine therapy. The Metallica study.Study to evaluate the effect of metformin in the prevention of hyperglycemiain HR[+]/HER2[–] PIK3CA-mutated advanced breast cancer patients treatedwith alpelisib plus endocrine therapy. The Metallica study.
CTIS2024-511295-33-00Medica Scientia Innovation Research S.L.88
招募中
3 期
Impact of metformin on pregnancy outcomes in overweight womePregnancy outcomes in overweight pregnancies.
IRCT20190716044229N1Oroumia University of Medical Sciences350
招募中
2 期
An assessment of the use of metformin in preventing prednisone-induced elevation in blood glucose levels among blood cancer patients at Kenyatta National Hospital
PACTR201807745027158ucy Ochola50